We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.68%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39B
AUM Growth
-$220M
(-0.56%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
4.06%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$592M |
| 2 |
Tesla
TSLA
|
+$492M |
| 3 |
Amazon
AMZN
|
+$474M |
| 4 |
Advanced Micro Devices
AMD
|
+$410M |
| 5 |
Qualcomm
QCOM
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$393M |
| 2 |
Union Pacific
UNP
|
+$363M |
| 3 |
Walmart Inc
WMT
|
+$239M |
| 4 |
Citigroup
C
|
+$192M |
| 5 |
ConocoPhillips
COP
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.84% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.47% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Globalstar
GSAT
$10.1B
| $455K | ﹤0.01% |
23,153
-42,020
| -64% | -$754K |
|
1827
Archrock
AROC
$6.16B
| $453K | ﹤0.01% |
35,954
-23,700
| -40% | -$284K |
|
1828
ANI Pharmaceuticals
ANIP
$1.86B
| $453K | ﹤0.01% |
7,800
-600
| -7% | -$34.6K |
|
1829
SandRidge Energy
SD
$503M
| $451K | ﹤0.01% |
28,800
-17,300
| -38% | -$277K |
|
1830
Gerdau
GGB
$9.54B
| $450K | ﹤0.01% |
+113,280
| New | +$503K |
|
1831
Limbach Holdings
LMB
$807M
| $447K | ﹤0.01% |
14,100
+1,700
| +14% | +$51.5K |
|
|
MTLS
1832
Materialise
MTLS
$366M
| $445K | ﹤0.01% |
81,100
-42,800
| -35% | -$307K |
|
1833
Global Ship Lease
GSL
$1.56B
| $444K | ﹤0.01% |
24,200
+500
| +2% | +$9.76K |
|
|
PTVE
1834
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $442K | ﹤0.01% |
54,400
+35,400
| +186% | +$289K |
|
1835
InterContinental Hotels
IHG
$23.8B
| $441K | ﹤0.01% |
+5,900
| New | +$441K |
|
1836
MacroGenics
MGNX
$233M
| $438K | ﹤0.01% |
93,900
-476,200
| -84% | -$2.37M |
|
|
NWLI
1837
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $437K | ﹤0.01% |
1,000
-700
| -41% | -$308K |
|
1838
BioAtla
BCAB
$5.34M
| $436K | ﹤0.01% |
5,134
-914
| -15% | -$116K |
|
1839
Bridgewater Bancshares
BWB
$580M
| $436K | ﹤0.01% |
46,000
-21,000
| -31% | -$216K |
|
1840
CRISPR Therapeutics
CRSP
$4.69B
| $436K | ﹤0.01% |
9,600
-7,700
| -45% | -$398K |
|
|
VNET
1841
VNET Group
VNET
$1.79B
| $435K | ﹤0.01% |
139,100
-1,700
| -1% | -$5.11K |
|
1842
Oramed Pharmaceuticals
ORMP
$162M
| $432K | ﹤0.01% |
165,600
-25,000
| -13% | -$78.7K |
|
1843
CapForce IBD 50 ETF
FFTY
$78.8M
| $432K | ﹤0.01% |
19,300
-10,200
| -35% | -$246K |
|
1844
Zeta Global
ZETA
$5.5B
| $432K | ﹤0.01% |
+51,700
| New | +$426K |
|
1845
First Community Bankshares
FCBC
$899M
| $429K | ﹤0.01% |
14,574
-2,500
| -15% | -$78.7K |
|
1846
Navigator Holdings
NVGS
$1.35B
| $428K | ﹤0.01% |
29,000
+6,600
| +29% | +$91.1K |
|
1847
SAP
SAP
$215B
| $427K | ﹤0.01% |
+3,300
| New | +$449K |
|
|
LOMA
1848
Loma Negra
LOMA
$1.34B
| $426K | ﹤0.01% |
70,700
-22,300
| -24% | -$144K |
|
1849
Guidewire Software
GWRE
$13.9B
| $423K | ﹤0.01% |
4,700
-11,600
| -71% | -$968K |
|
1850
Domo
DOMO
$171M
| $423K | ﹤0.01% |
43,100
-41,300
| -49% | -$574K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Two Sigma Advisers held 2,663 positions worth $39B, down 0.56% from $39.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers deployed $1.59B of net new capital in Q3 2023, opening 306 new positions and adding to 844 existing holdings. Its largest new stake was Advanced Micro Devices: 3,777,240 shares worth $388M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Charles Schwab, an estimated $393M trimmed.
- Two Sigma Advisers's largest Q3 2023 buy was Advanced Micro Devices: 3,777,240 shares worth $388M.
- Two Sigma Advisers added most to Microsoft in Q3 2023, an estimated $592M increase.
- Two Sigma Advisers's biggest Q3 2023 reduction was Charles Schwab, cutting an estimated $393M.
- Two Sigma Advisers fully exited Uber in Q3 2023, selling an estimated $109M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $39B portfolio in Q3 2023.
- Two Sigma Advisers opened 306 new positions and closed 301 in Q3 2023.
- Two Sigma Advisers's portfolio value fell 0.56% quarter-over-quarter to $39B.
Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.